However, a previous study by Dank et al. showed that high levels of the PD-L1 soluble form (sPD-L1) in plasma were significantly associated with increased tumor burden and shorter disease-specific survival and progression-free survival in metastatic CRC patients [25]. This evidence concerns the gene CD274 and neoplasm.